Lyell Immunopharma Inc.

NASDAQ: LYEL · Real-Time Price · USD
13.41
5.42 (67.83%)
At close: Jun 04, 2025, 3:59 PM
13.39
-0.15%
After-hours: Jun 04, 2025, 07:59 PM EDT
67.83%
Bid 13.09
Market Cap 210.99M
Revenue (ttm) 65K
Net Income (ttm) -334.52M
EPS (ttm) -25
PE Ratio (ttm) -0.54
Forward PE -11.87
Analyst Hold
Ask 13.75
Volume 1,641,292
Avg. Volume (20D) 43,485
Open 8.02
Previous Close 7.99
Day's Range 7.78 - 13.76
52-Week Range 7.65 - 53.90
Beta -0.27

About LYEL

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LYEL
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for LYEL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
7 months ago
+19.35%
Lyell Immunopharma shares are trading higher. The ... Unlock content with Pro Subscription
7 months ago
-5.22%
Lyell Immunopharma shares are trading higher after the company announced it will acquire privately-owned clinical-stage biotechnology company ImmPACT Bio.